Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

Mizuho’s Jared Holz on what is next for Sarepta after second death connected to gene therapy

June 16, 2025

Jared Holz, Mizuho, joins ‘Fast Money’ to talk the fallout for Sarepta after another death related to its muscular dystrophy gene therapy.

Share This

Latest Mizuho News

Selective opportunities in software stocks amid sell-off, says Mizuho’s Gregg Moskowitz

Selective opportunities in software stocks amid sell-off, says Mizuho’s Gregg Moskowitz

February 17, 2026

Eli Lilly has already won the weight loss drug battle, says Mizuho’s Jared Holz

Eli Lilly has already won the weight loss drug battle, says Mizuho’s Jared Holz

February 23, 2026

Polymarket settling with USDC helped drive our upgrade of Circle, says Mizuho’s Dan Dolev

Polymarket settling with USDC helped drive our upgrade of Circle, says Mizuho’s Dan Dolev

February 25, 2026

Mizuho news from around the globe

Mizuho Global News